Helping you test and confirm the identity of your large molecule drug
Utilize our technology and expertise in the identification of biological products during your late drug discovery workflow to help you establish the specific type of molecule that’s being developed and launched as a therapeutic.
With a variety of techniques available to confirm the identity of the biological product whether that’s a monoclonal antibody, recombinant protein, nucleic acid vectors or viral vectors, we can support the identification of the large molecule of interest or active therapeutic to assist downstream characterization, scale up, purification, and compliant release of the final product.
We offer a wide array of molecular, biochemical, bioanalytical, and analytical solutions to help facilitate unambiguous detection of the large therapeutic molecule of interest and mitigate several of the challenges faced in later stages of drug development.
For research use only. Not for use in diagnostic procedures.
